Mike Hogan Ph.D.: Chairman of the Scientific Advisory Board, An internationally recognized expert in the physical chemistry of applied genetics. Previously, Dr. Hogan was a founder of Triplex Pharmaceuticals, Genometrix and GenVault. Dr. Hogan held academic appointments at Princeton University and Baylor College of Medicine and Texas A&M and sits on several NIH panels in translational biology, companion diagnostics, and biospecimen science.
Paul Dunn Ph.D., ASHI Director and HLA Advisor, has 13 years experience in tissue typing and the development of HLA typing technologies. Paul graduated with BSc(hons) in Biochemistry from the University of London and a PhD in Protein Biochemistry from the University of Sussex. Following post-doctoral fellowships at the University of Cambridge in Molecular Biology and Genetic Engineering Paul moved into the field of Histocompatibility, firstly in the development of DNA sequencing for HLA Typing at UK Transplant in Bristol UK (1995-2000). Paul was then recruited by The National Blood Service as EFI Director of the tissue typing laboratory and British Bone Marrow Registry in Bristol (2000-2005). In the beginning of 2005 Paul moved to New Zealand as ASHI Director of the National Tissue Typing Laboratory and in July 2008 was recruited by GMSbiotech to oversee ASHI certification and to advise on HLA typing and technologies. Paul has more than 50 articles published in the fields of protein biochemistry, gene analysis and expression, HLA typing and transfusion.
Kamala Balakrishnan, MD., Advisor, is Emeritus Professor of Transfusion Medicine at the University of Cincinnati, College of Medicine. She graduated from the Christian Medical College in Vellore, a renowned institution. Her postgraduate training in Pathology was at the prestigious Armed Forces Medical College in Pune, and subsequent training in immunology was at the University of Birmingham in the UK. She was instrumental in establishing the first histocompatibility testing laboratory at the All India Institute of Medical Sciences, leading to the provision of HLA typing and crossmatch services for renal transplantation in India. She was also a Founder member of the Indian Immunology Society and a faculty member of the WHO courses at AIIMS. After relocating to the USA, she was the Scientific Director of the American Red Cross at Toledo and the Director of the Histocompatibility Laboratory as well as a faculty member of the Department of Pathology at the Medical College of Toledo. She subsequently moved to the University of Cincinnati where she served as the Director of the Histocompatibility Laboratory for nineteen years. She was also a faculty member of the Department of Medicine, Pathology and Transfusion Medicine. Dr. Balakrishnan is a former President of the American Society for Histocompatibility and Immunogenetics and served also as the Chair of the ASHI Accreditation Committee. She has served as the histocompatibility representative from ASHI to the UNOS Board (United Network for Organ Sharing) and is also a former Chair of the NMDP International Committee. After completing her services at Cincinnati, she served as part-time director to train and guide the HLA laboratory directors at the Blood Center of Indiana and the Community Blood Center at Dayton through the process of obtaining ASHI accreditation.